|
|
| Year : 2011 | Volume
: 5
| Issue : 1 | Page : 42-45 |
|
| Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan |
|
|
Fawwaz Al-Joudi1, Anuar Bin Ali2, Majdan Bin Haj Ramli2, Suhair Ahmed3, Mohd Ismail4
1 Department of Biomedical Science, Faculty of Allied Health Sciences, National University of Malaysia, Kuala Lumpur, Malaysia
2 Unit of Haematology, Hospital Raja Perempuan Zainab II, Kota Bharu, Malaysia
3 Department of Haematology and Blood Transfusion, School of Medical Sciences, University of Science of Malaysia, Kota Bharu, Malaysia
4 Department of Community Medicine, School of Medical Sciences, University of Science of Malaysia, Kota Bharu, Malaysia
Click here for correspondence address and email
| Date of Web Publication | 21-Jan-2011 |
|
|
 |
|
 Abstract | | |
Background: Red blood cell (RBC) alloantibodies may be formed following exposure to RBC antigens. In most cases, the alloimmunization develops during pregnancy or from previous blood transfusions. The RBC antigens and their alloantibodies vary among different human populations and ethnic groups, and they do have a clinical significance for their adverse immunological reactions. Aims: This study aimed at studying the prevalence of RBC alloantibodies at the Blood Transfusion Unit of Hospital Raja Perempuan Zainab II in Kota Bharu, Malaysia. Patients and Methods: A cross-sectional study was performed utilizing data obtained in the years 2007 and 2008. Data of antibody screening tests from 5719 patients were examined. Results and Discussion: The overall prevalence of alloimmunization was 65 (1.13%). The majority of these had a single alloantibody (76.9%), whereas the remaining 23.1% had multiple antibodies. The anti-E antibody comprised the most common alloantibody (24.6%) followed by the anti-Lewis (a) antibodies (18.5%) and the anti-M antibody (13.8%). There were more female recipients than males. Conclusions: It was concluded that the findings of this work have been comparable with other published works, and that the main factors associated with alloantibody formation were multiple transfusions and pregnancies. The study also emphasizes the necessity for carrying out immunohematology studies prior to every blood transfusion especially in cases that require multiple transfusions for a long period of time such as in thalassemia patients. Keywords: RBC antigens, alloantibodies, blood transfusion
How to cite this article:
Al-Joudi F, Ali AB, Ramli MB, Ahmed S, Ismail M. Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan. Asian J Transfus Sci 2011;5:42-5 |
How to cite this URL:
Al-Joudi F, Ali AB, Ramli MB, Ahmed S, Ismail M. Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan. Asian J Transfus Sci [serial online] 2011 [cited 2023 Mar 22];5:42-5. Available from: https://www.ajts.org/text.asp?2011/5/1/42/75997 |
| Introduction | |  |
Many blood group antigens and their genes have been identified, and their physiological roles uncovered, and have been found to be important determinants in transfusion medicine. Approximately, 400 red blood cell (RBC) antigens have been identified. These RBC antigens and alloantibodies differ significantly among human populations and ethnic groups. Hence, alloimmunization after exposure to red cell alloantigens depends on genetic and acquired patient-related factors, dose, and the immunogenicity of the antigens. [1],[2] The exact kinetics of alloimmunization are not clear. [3],[4] The development of alloantibodies can significantly complicate transfusion therapy and result in difficulties in cross-matching of blood. Clinically, significant antibodies are capable of causing mild or severe adverse events following transfusion, such as hemolytic disease of the fetus and newborn. Thus, knowledge of such alloantibodies is essential for selecting appropriate RBC products for transfusion. [5] Antibodies that may cause hemolysis include those specific to most of the major and the minor blood groups. [3],[5],[6],[7],8[],[9] One report on autoantibodies to red cells in thalassemia patients in Kelantan has been published. [10] This work was carried out at Hospital Raja Perempuan Zainab II, to determine the prevalence and distribution of RBC alloantibodies among blood recipients in Kelantan State.
| Materials and Methods | | |
This is a retrospective cross-sectional study that utilized data of all patients admitted at Hospital Raja Perempuan Zainab II, Kota Bharu Kelantan during the years 2007 and 2008. Patients with missing data were excluded from the study. The essential data sought were those of alloantibodies obtained during routine screening and immunohematological investigations such as group, screen and hold (GSH) as part of the support of the transfusion service at the hospital. Other information sought for each patient included medical history, gender, age, and ethnic origin. Screening for antibodies utilized commercially prepared RBC test panels. In total, there were data from 5719 patients recruited in the study. The data were analyzed using the Statistical Package for the Social Sciences (SPSS) software Version 16.0.
| Results | | |
The initial investigations showed that the majority of the recipients were female patients, most of whom were Malays, followed by Chinese, Siamese, Indians, and aboriginis, the Orang Asli. Their mean age was 39.12 ± 16.5 years old [Table 1] and [Figure 1]. The medical histories were widely distributed, though dominated by pregnancies and anemias [Figure 2]. Of all the records investigated, only 65 patients (1.13%) were found to be positive for alloantibodies to RBC antigens (95% CI: 0.8-1.4). However, there were another 32 patients who harbored serum autoantibodies [Table 2]. The blood types records showed that 23 patients had blood group A, Rhesus positive (35.4 %), 21 patients had blood group B, Rhesus positive (32.3%), 17 patients with blood Group O, Rhesus positive (26.2 %), and 3 patients with blood group AB, Rhesus positive (4.6 %). In addition, there was one patient with blood group O, Rhesus negative 1 (1.5 %) [Table 3] of the 65 patients with alloantibodies, 50 patients (76.9%) had a single alloantibody, whereas 15 patients (23.1%) had multiple alloantibodies [Table 4]. Investigating the alloantibody specificities detected mostly Anti-E, Anti-Lewis (a), and Anti-M [Table 5]. | Table 2 :The prevalence of alloantibodies and autoantibodies among the study patients
Click here to view |
 | Table 4 :The distribution of RBC alloantibodies based on number of alloantibodies in each study subject (n = 65)
Click here to view |
 | Figure 2 :A bar chart showing the sample distribution according to their medical histories
Click here to view |
The factors that associated with the development of RBC alloantibodies were also investigated. The total number of patients with complete data in their case records was 400. The variables tested showed that male patients had the odds ratio of 0.08 for developing alloantibody as compared to female patients. In addition, patients with histories of previous blood transfusions were 2.35 times more liable to developing alloantibodies compared to those with no histories of blood transfusions. Furthermore, blood group A-positive patients showed odds of developing alloantibodies as high as 12.21 when compared to patients with other blood groups [Table 6]. Moreover, female patients appeared to be significantly more liable to developing alloantibodies than male patients [Table 7]. The ethnic grouping showed that the prevalence of alloantibody associated stronger with the Malay group than with non-Malay groups [Table 8]. | Table 6 :The factors associated with the development of RBC alloantibody (n = 400)
Click here to view |
 | Table 7 :The association between frequency of alloantibody formation and gender
Click here to view |
| Discussion | | |
The incidence of alloimmunization against RBC antigens depends on the demography of the population being studied. Previous data from a number of communities describe alloimmunization following transfusions for indications such as anemia, thalassemia, and end-stage renal failure (ESRF). [3],[11],[12],[13] Such data and its related clinical indications were not available in Kelantan, Malaysia.
The overall prevalence of alloimmunization among blood recipients in this work is comparable with rates previously reported on patients receiving transfusion. This study shows that the majority of the study subjects have single rather than multiple alloantibodies of which anti-E was the most common alloantibody found followed by anti-Lewis (a) and anti-M, which may be determined genetically. The anti-E was detected in almost all available studies at relatively high levels. Others with somewhat widely distributed expression are the alloantibodies against anti-Lewis (a) and anti-Lewis (b). This remark suggests that anti-E and Lewis alloantibodies are the most common alloantibodies among populations. Furthermore, it implies that the E antigen and the Lewis (a and b) antigens are highly immunogenic and that they are expressed differentially among individuals of one community. In other words, the absence of antigen E may render a recipient prone to sensitization by the E antigen that comes from an E-positive donor. [14] This explanation marks the necessity for RBC phenotyping to stop unnecessary sensitization to RBC antigens, and to aid in avoiding unwanted clinical consequences.
In this study, as in most other studies, the incidence of alloimmunization among females is more predominant than in male patients, possibly because most of the blood recipients are females, especially those with histories of eventful pregnancies. Hence, immunization through pregnancy could be one main reason for the high incidence of RBC alloimmunization among female patients. However, female patients were reported not to be a majority once. [15] The ethnic distribution of alloantibodies indicates that Malays are predominantly affected, which is attributable to the fact that Kelantan State is populated by a great majority of Malays. Also expected, patients who had experienced blood transfusions were found to be more liable to developing alloantibodies than those who never experienced a blood transfusion. Similar findings have been indicated in other works. [12],[16] However, the statistical association between the development of alloantibodies with blood group A was not clear. No such remark has been reported.
Nevertheless, this work represents a pilot study, which attempted to shed some light into the blood groups that have the potential for alloantibody formation. Hence, two things are recommended, knowledge of prevalent RBC antigens in a community and routine investigation for alloantibodies in blood donors.
| Acknowledgments | | |
Thanks are due to the administration and the Records Office at Hospital Perempuan Zainab II for their kind cooperation during the course of this work.
| References | | |
| 1. | Cartron JP, Collin Y. Structural and Functional Diversity of blood group antigens. Transfus Clin Biol 2001;8:163-99. 
|
| 2. | Siegel DL. The human immune response to red blood cell antigens a revealed by repertoire cloning. Immunol Res 1998;17:3239-51.
|
| 3. | Lee CK, Ma ES, Tang M, Lam CC, Lin CK, Chan LC. Prevalence and specificity of clinically significant red cell alloantibodies in Chinese women during pregnancy- a review of cases from 1997 to 2001. Transfus Med 2003;13:227-31.
[PUBMED] [FULLTEXT] |
| 4. | Singer ST, Wu V, Mignacca R, Kuypers FA, Morel P, Vichinsky EP. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent. Blood 2000;96:3369-73.
[PUBMED] [FULLTEXT] |
| 5. | Poole J, Daniels G. Blood Group Antibodies and Their Significance in Transfusion Medicine. Transfus Med Rev 2007;21:58-71.
[PUBMED] [FULLTEXT] |
| 6. | Wong KF, Tse KT, Lee AW, Mak CS, So CC. Is antenatal antibody screening worthwhile in Chinese. Brit J Haematol 1997;97:917-9.
|
| 7. | Spanos T, Karageorga M, Ladis V, Peristeri J, Hatziliami A, Kattamis C. Red cell alloantibodies in patients with thalassemia. Vox Sanguinis 1990;58:50-5.
[PUBMED] |
| 8. | Stahl D, Lacroix-Desmazes S, Sibrowski W, Kazatchkine MD, Kaveri SV. Red blood cell ransfusions are associated with alterations in self-reactive antibody repertoires of plasma IgM and IgG, independent of the presence of a specific immune response toward RBC antigens. Clin Immunol 2002;105:25-35.
[PUBMED] [FULLTEXT] |
| 9. | Hillyer CD. Handbook of transfusion medicine. Academic Press; 2001.
|
| 10. | Noor Haslina MN, Ariffin N, Illuni Hayati I, Rosline H. Red cell autontibodies among thalassaemia patients in Hospital Universiti Sains Malaysia. Singapore Med J 2007;48:922-5.
[PUBMED] [FULLTEXT] |
| 11. | Ameen R, Al-Eyaadi O, Al-Shemmari S, Chowdhury R, Al-Bashir A. Frequency of Red Blood Cell Alloantibody in Kuwaiti Population. Med Princ Pract 2005;14:230-4.
[PUBMED] [FULLTEXT] |
| 12. | Wang LY, Liang DC, Liu HC, Chang FC, Wang CL, Chan YS, et al. Alloimmunization among patients with transfusion dependent thalassemia in Taiwan. Transfus Med 2006;16:200-3.
[PUBMED] [FULLTEXT] |
| 13. | Winters JL, Pineda AA, Gorden LD, Bryant SC, Melton LJ 3rd, Vamvakas EC, et al. RBC alloantibody specificity and antigen potency in Olmsted County, Minnesota. Transfusion 2001;41: 1413-20.
[PUBMED] [FULLTEXT] |
| 14. | Yamane K, Yagihashi A, Sasaki M, Kuwashima K, Morio A, Watanabe N. A delayed hemolytic transfusion reaction (DHTR) with multiple alloantibodies (Anti-E, Jka, Dia, Fyb, and S) induced by E-antigen-negative, crossmatch-compatible blood. Immunoph Immuno 1998;20:531-9.
|
| 15. | Blumberg N, Peck K, Ross K, Avila E. Immune response to chronic red blood cell transfusion. Vox Sanguinis 1983;44:212-7.
[PUBMED] |
| 16. | Sakhalkar VS, Roberts K, Hawthorne LM, McCaskill DM, Veillon DM, Caldito GC, et al. Allosensitization in patients receiving multiple blood transfusions. Ann N Y Acad Sci 2005;1054:495-9.
|
Correspondence Address:
Fawwaz Al-Joudi
Department of Biomedical Science, Faculty of Allied Health Sciences, National University of Malaysia, Jalan Raja Muda Abdul-Aziz, 50300 Kuala Lumpur
Malaysia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0973-6247.75997
[Figure 1], [Figure 2]
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6], [Table 7], [Table 8] |
|
| This article has been cited by | | 1 |
Kidd Blood Group Genotyping for Thalassemia Patient in Iran |
|
| Seyedeh Farzaneh Jalali, Arezoo Oodi, Azita Azarkeivan, Samira Gudarzi, Naser Amirizadeh | | Indian Journal of Hematology and Blood Transfusion. 2020; 36(3): 550 | | [Pubmed] | [DOI] | | | 2 |
Extended blood group profiles for Malays, Chinese, and Indians in Peninsular Malaysia |
|
| Che Ghazali Norul Hajar, Zulkafli Zefarina, Nor Suhaila Md. Riffin, Tuan Hulwani Tuan Mohammad, Mohd Nazri Hassan, Prathapan Poonachi, Sabreena Safuan, Gehad ElGhazali, Geoffrey Keith Chambers, Hisham Atan Edinur | | Egyptian Journal of Medical Human Genetics. 2020; 21(1) | | [Pubmed] | [DOI] | | | 3 |
Red cell alloimmunization in oncology patients :A study from eastern India |
|
| Supriya Dhar,Sabita Basu | | Transfusion and Apheresis Science. 2015; | | [Pubmed] | [DOI] | | | 4 |
Prevalence and specificity of RBC alloantibodies in the general hospitalised population in Guangxi |
|
| Z. Mo,H. Li,L. Huang,W. Jiao | | Transfusion Medicine. 2015; 25(5): 313 | | [Pubmed] | [DOI] | | | 5 |
Frequency and Specificity of Red Blood Cell Alloimmunization in Chilean Transfused Patients |
|
| José Caamaño, Evangelina Musante, Margarita Contreras, Hernán Ulloa, Carolina Reyes, Verónica Inaipil, Nicolás Saavedra, Neftalí Guzmán | | Transfusion Medicine and Hemotherapy. 2015; 42(1): 4 | | [Pubmed] | [DOI] | | | 6 |
Presence of Irregular Antibody (Anti-c) in a Multitransfused Cardiac Surgery Patient |
|
| R. S. Mallhi,U. Dimri,D. R. S. A. Jayamanna,J. Philip | | Indian Journal of Hematology and Blood Transfusion. 2014; | | [Pubmed] | [DOI] | | | 7 |
Prevalence and Specificity of RBC Alloantibodies in Indian Patients Attending a Tertiary Care Hospital |
|
| Shamsuz Zaman,Rahul Chaurasia,Kabita Chatterjee,Rakesh Mohan Thapliyal | | Advances in Hematology. 2014; 2014: 1 | | [Pubmed] | [DOI] | | | 8 |
Hemolytic disease of the fetus and newborn caused by anti-E |
|
| Usman, A.S. and Mustaffa, R. and Ramli, N. and Diggi, S.A. | | Asian Journal of Transfusion Science. 2013; 7(1): 84-85 | | [Pubmed] | | | 9 |
Red cell phenotyping of blood from donors at the National blood center of Malaysia |
|
| Musa, R.H. and Ahmed, S.A. and Hashim, H. and Ayob, Y. and Asidin, N.H. and Choo, P.Y. and Al-Joudi, F.S. | | Asian Journal of Transfusion Science. 2012; 6(1): 3-9 | | [Pubmed] | |
|
|
|
|
|
|
|
|
|
|
|
|
| Article Access Statistics | | | Viewed | 7393 | | | Printed | 278 | | | Emailed | 4 | | | PDF Downloaded | 130 | | | Comments | [Add] | | | Cited by others | 9 | | |
|
|
